Search | Invivogen

Human BCMA x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hBCMA-βgal

Human EpCAM x E. coli β-Gal Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-hEpCAM-βgal

Human EpCAM x Human CD3 Bispecific Antibody

Solitomab scFv antibody - Recombinant

Evaluation of T cell activation (ELISA)

Human IL-6R (CD126) Antibody - Tocilizumab IgG1NQ Isotype

Human IgG1 Fc silent

Inhibition of IL-6R signaling by Anti-hIL6R-To-hIgG1NQ

Human BCMA x Human CD3 Bispecific Antibody

Pacanalotamab scFv antibody - Recombinant

Evaluation of T cell activation

Human VISTA Antibody - Onvatilimab IgG1NQ Isotype

Human IgG1, Fc silent

Binding of Anti-hVISTA-hIgG1 to target cells

ADCC potency of native and engineered Anti-hVISTA isotype family

ADCC assay with Raji-hVISTA cells

E. coli β-Gal x Human CD3 Bispecific Antibody - Negative Control

Control scFv antibody - Recombinant

Activation of Jurkat-Lucia™ NFAT cells with Anti-hCD19-CD3

Anti-βgal-hCD3 does not allow Jurkat-Lucia™ NFAT cell activation

Human CD19 x E. coli β-Gal Bispecific Antibody - Negative control

Control scFv antibody - Recombinant

Activation of Jurkat-Lucia™ NFAT cells with Anti-hCD19-CD3

Absence of Jurkat-Lucia™ NFAT cell activation using Anti-βgal-hCD3

Human CD19 x Human CD3 Bispecific Antibody

Blinatumomab scFv antibody - Recombinant

Evaluation of T cell activation

Target specificity of Anti-hCD19-CD3

Jurkat-Lucia™ NFAT cell activation

Activation of Jurkat-Lucia™ NFAT cells with Anti-hCD19-CD3

Anti-hPD1-Pem-hIgG1NQ

Human PD-1 (pembrolizumab) antibody - Human IgG1, non-glycosylated

Default product image